Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

IP Forecast: Cooley Atty Faces DQ Bid Over Past Patent Work No Photo Available

Andrew Karpan

A prominent Cooley LLP lawyer will face questions next week in a Philadelphia courtroom over her work a decade ago at her former firm ... (more story)

Justices Hand Abortion Advocates An Incomplete Win No Photo Available

Dan McKay

The U.S. Supreme Court's rejection Thursday of a challenge to the abortion drug mifepristone will do little to safeguard long-term acc... (more story)

Thomas Targets Group Standing In Mifepristone Ruling No Photo Available

Katie Buehler

U.S. Supreme Court Justice Clarence Thomas joined his colleagues Thursday to unanimously uphold broad access to the abortion medicatio... (more story)